Evgen Pharma Plc

Evgen Pharma (EVG)

Buy
Sell
Company name:Evgen Pharma Plc
Company Description:Evgen Pharma is a clinical stage drug development company whose lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke.
EPIC:EVGTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BSVYN304
Market Segment:ASQ1Share Type:DE
WWW Address:www.evgen.comDescription:ORD 0.25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 14.05 images.advfn.com/imagesnew/2/gb/up 0.35 [2.55] 13.85 14.25 13.70 14.05 13.70 217,764
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 19.29 137.30 -0.00 -2.10 - - - 20.00 - 2.75

Evgen Pharma Key Figures

(at previous day's close)
Market Cap.19.29m
Shares In Issue137.30m
Prev. Close13.70
PE Ratio- 
Dividend Yield-%
EPS - basic-2.10p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.88p
Return On Equity (ROE)-75.31%
Operating Margin-%
PEG Factor- 
EPS Growth Rate23.36%
Dividends PS Growth Rate-%
Net Debt-3.48m
Gross Gearing13.44%
Quick Assets4.77m
Net Working Capital4.12m
Intangibles / Fixed Assets97.62%
Turnover PS-p
Pre-Tax Profit PS-2.31p
Retained Profit PS-2.31p
Cash PS3.01p
Net Cash PS2.53p
Net Tangible Asset Value PS *3.00p
Net Asset Value PS3.06p
Spread0.40 (2.81%) 

Evgen Pharma Balance Sheet

LSE:EVG:Liabilities+EQLSE:EVG:Assets

Share Price Performance

Sample Period HighLow
1 week14.2512.25
4 weeks14.857.95
12 weeks14.857.95
1 year20.002.75

Share Price Chart (5 years)

Evgen Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week13.100.957.2512.251.6713.64
4 weeks8.655.4062.437.954.1111.37
12 weeks13.880.181.267.953.3511.47
26 weeks4.259.80230.592.752.1010.63
1 year17.13-3.08-17.962.751.2910.49
3 years21.50-7.45-34.652.750.6012.63
5 years42.50-28.45-66.942.750.4213.15

Evgen Pharma Key Management Ratios

Evgen Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 5.06 
Tobin's Q Ratio (excl. intangibles)5.18 
Dividend Yield-%
Market-to-Book Ratio4.59 
Price-to-Pre-Tax Profit PS-6.09 
Price-to-Retained Profit PS-6.09 
Price-to-Cash Flow PS-7.49 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS4.68 
Price-to-Cash PS4.67 
Net Working Capital PS3.00 
Price Pct to Working Capital PS4.68%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Evgen Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-71.61%
Net Gearing (excl. Intangibles)-72.84%
Gross Gearing13.44%
Gross Gearing (excl. Intangibles)13.68%
Gearing Under 1 Year13.44%
Gearing Under 1 Year (excl. Intgbl)13.68%
Assets/Equity1.16 
Cash/Equity98.26 
(Liquidity Ratios)
Net Working Capital to Total Assets84.83%
Current Ratio7.31 
Quick Ratio (Acid Test)7.31 
Liquidity Ratio6.33 
Cash & Equiv/Current Assets86.55%
(Solvency Ratios)
Enterprise Value15.16m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.53 
CFO/Debt-3.94 
Total Debt/Equity Market Value0.03 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.21 
Total Debt0.65m
Total Debt/Net Current Assets0.16%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-13.81%
5 yr Compound Earnings Growth-19.70%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
-0.00070.0071

Evgen Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-75.31%
Return On Assets (ROA)-83.09%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-75.31%
Return On Investment (ROI)-100.83%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Evgen Pharma Dividends

Sorry No Data Available

Evgen Pharma Fundamentals

 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
turnover--------m
pre tax profit-3.64--3.03--3.12--3.17-m
attributable profit-3.07--2.58--2.62--3.17-m
retained profit-3.07--2.58--2.62--3.17-m
eps - basic (p)-4.19 -3.28 -2.74 -2.10 
eps - diluted (p)-4.19 -3.28 -2.74 -2.10 
dividends per share- - - - 

Evgen Pharma Balance Sheet

 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
LSE:EVG:Liabilities+EQLSE:EVG:AssetsLSE:EVG:Liabilities+EQLSE:EVG:AssetsLSE:EVG:Liabilities+EQLSE:EVG:AssetsLSE:EVG:Liabilities+EQLSE:EVG:Assets
 31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
ASSETS
fixed assets fixed assets0.010.23%0.010.28%0.010.22%0.000.04%m
intangibles intangibles0.132.70%0.112.65%0.103.55%0.081.69%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors0.7415.69%0.5111.95%0.6322.68%0.6413.22%m
cash & securities cash & securities3.8681.38%3.6385.12%2.0373.55%4.1385.05%m
TOTAL4.74100%4.26100%2.76100%4.86100%m
LIABILITIES
creditors - short creditors - short0.5110.84%0.399.13%0.6924.89%0.6513.44%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL0.5110.84%0.399.13%0.6924.89%0.6513.44%m
EQUITY
ord cap, reserves ord cap, reserves4.2389.16%3.8790.87%2.0875.11%4.2086.56%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL4.2389.16%3.8790.87%2.0875.11%4.2086.56%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Evgen Pharma Cash Flow Statement

31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)
Operating CF-3.19-2.34-2.29-2.58m
Pre-Financing CF-1.26-2.35-2.29-2.58m
Retained CF-1.26-0.23-1.592.10m

Evgen Pharma Brokers

NameActivityTypeMnemonicCode
Altium Capital LimitedMarket Maker(MME)Broker/DealerALTIAPCFGB21
Arden Partners PlcMarket Maker(MME)Broker/DealerARDAARRRGB2100A
CREDIT SUISSE SEC (EUROPE) LTDMarket Maker(MME)Broker/DealerCSFBCSFBGB2L
Goldman Sachs InternationalMarket Maker(MME)Broker/DealerGSCOGSILGB2X
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Citigrp Global Mkt UK EquitiesMarket Maker(MME)Broker/DealerCITISBUKGB21
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
UBS AGMarket Maker(MME)Broker/DealerUBS.UBSWGB2LEQU
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
EVG
Evgen Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200810 09:03:26